Neuroinflammation is a shared pathological foundation for depression, anxiety, chronic pain, and neurodegenerative diseases. Unlike traditional peripheral inflammation, which occurs within the blood-brain barrier and is mediated by microglia and astrocytes, it often resists conventional anti-inflammatory drugs. Functional medicine's emotional cognition and brain health dimension identifies neuroinflammation as a key modifiable target for mood disorders.
N-palmitoylethanolamide (PEA) is a fatty acid amide naturally produced in the human body and found in foods such as eggs, soybeans, peanuts, and milk. PEA works primarily by activating PPAR-α (peroxisome proliferator-activated receptor alpha), which inhibits the activation of microglia and mast cells and reduces the release of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) and chemokines.
Another key mechanism of PEA is "endocannabinoid enhancement." By inhibiting fatty acid amide hydrolase (FAAH), PEA slows the degradation of the endogenous cannabinoid anandamide (AEA), thereby boosting signaling within the endocannabinoid system. Known as the "bliss molecule" (from the Sanskrit *ananda*, meaning "joy"), anandamide plays a critical role in mood regulation, pain perception, and reward pathways.
Multiple meta-analyses and randomized controlled trials confirm PEA's clinical value: Daily supplementation of 300-1200 mg PEA for 2-8 weeks significantly improves chronic pain (neuropathic pain, fibromyalgia, low back pain), anxiety scores, and depressive symptoms. PEA has an excellent safety profile—no central nervous system side effects (no drowsiness, cognitive impairment, or dependence), no drug interactions, and can be used in combination with conventional analgesics and antidepressants.
In functional medicine product development, PEA is an innovative ingredient in our Emotional Cognitive Brain Health series. Unlike traditional GABAergic sedatives (such as L-theanine and GABA), PEA supports emotional well-being through anti-inflammatory mechanisms and endocannabinoid modulation, establishing a new paradigm of "neuroinflammatory-based emotional support." Paired with Omega-3 (providing pro-resolving SPMs) and Magnesium Glycinate (NMDA receptor modulator), it delivers a multi-dimensional approach to emotional balance targeting inflammation, the endocannabinoid system, and neurotransmitters. Hong Kong Dynas Group Co., Ltd. offers OEM/ODM customization for both capsule and powder formats.
